The partnership focuses on developing a digital module for renal cell carcinoma. Credit: Marko Aliaksandr/Shutterstock.com.

Elekta has announced a collaboration with Merck & Co (MSD) to enhance care for individuals with advanced renal cell carcinoma (RCC) through the use of digital patient monitoring.

This initiative utilises Elekta’s digital health interventions platform, Kaiku Health, for patient engagement and monitoring of reported outcomes.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Elekta said the partnership focuses on developing a digital module that connects patients with their care team and educates them about their condition, treatment options, and potential side effects.

MSD global oncology marketing vice-president Marc Gailhardou said: “By combining forces, we aim to empower patients and healthcare providers to optimise patients’ treatment journey and enable shared treatment decisions and communication.”

The digital module will provide comprehensive symptom monitoring along with patient support, ensuring that individuals receive tailored and timely assistance.

See Also:

It will also offer digital education and support materials specifically designed for patients undergoing immuno-oncology (IO)-tyrosine kinase inhibitor combination therapy for advanced RCC.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Elekta business line software head and senior vice-president Anish Patankar said: “Addressing potential challenges in cancer care involves the implementation of digital patient support. With the support of MSD, our shared objective is to improve communication between patients and their care teams.

“This initiative aims to provide structured support for symptom management and monitoring while also educating patients about their disease and treatment.”

The module is planned to be validated through collaborations with cancer clinics across Europe this year.

Last year, Elekta partnered with Bristol Myers Squibb to develop a digital solution for melanoma patients.

Leveraging Kaiku Health, the partnership will facilitate healthcare professionals and their patients’ communication on symptom management.